Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Kunio, Ono"'
Autor:
Katsuyuki Taguchi, Takanari Sakai, Naoe Akimoto, Satoshi Kanto, Masahiko Sato, Kunihisa Nezu, Senji Hoshi, Kiyotsugu Hoshi, Kenji Numahata, Kunio Ono, Akihito Kuromoto, Shoichiro Ohta, Hideaki Izumi, Rika Takahashi, Yuichi Ishizuka, Bilim Vladimir, Hidenori Kanno, Isoji Sasagawa, Chihito Konno
Publikováno v:
Molecular and Clinical Oncology. 7:591-594
Molecular-targeted therapy was recommended for the systemic therapy of renal cell cancer (RCC) in the RCC guidelines, but these guidelines do not address the order of administration of the multiple presently available agents. There are several aspect
Autor:
Nobuhiro Yasuno, Kiyotsugu Hoshi, Kunio Ono, Vladimir Bilim, Hiroshi Amemiya, Kenji Numahata, Isoji Sasagawa, Senji Hoshi, Shoichiro Ohta
Publikováno v:
Molecular and Clinical Oncology. 7:601-603
In recent years, abiraterone acetate (AA) and enzalutamide (EZL) have become available for the treatment of cancer. Prior clinical trials have demonstrated the benefits of these agents in males with castration-resistant prostate cancer (CRPC). The op
In vitro refolding process of urea-denatured microbial transglutaminase without pro-peptide sequence
Autor:
Yokoyama, Kei-ichi, Kunio, Ono, Ohtsuka, Tomoko, Nakamura, Nami, Seguro, Katsuya, Ejima, Daisuke
Publikováno v:
In Protein Expression and Purification 2002 26(2):329-335
Autor:
Satoru Kanto, Kunio Ono, Mituharu Sasaki, Isoji Sasagawa, Yuuichi Ishizuka, Teppei Ookubo, Kiyotugu Hoshi, Kunihisa Nezu, Senji Hoshi, Hidenori Kanno, Vladimir Bilim, Kenji Numahata, Hideaki Izumi
Publikováno v:
Journal of Urology. 193
Publikováno v:
Protein Expression and Purification. 47:45-51
A general approach for refolding recombinant proteins from inclusion bodies (IBs) is to screen conditions, that facilitate a conversion of unfolded to folded structure and minimize a conversion of unfolded to misfolded and aggregated structures. In t
Publikováno v:
The Journal of the Japanese Society of Clinical Cytology. 44:245-249
背景:膀胱の肉腫様癌はきわめてまれであり, 肉腫様癌の尿細胞診についての報告はない.症例:症例1: 59歳, 女性. 膀胱頂部に隆起性腫瘤をみた. 尿細胞診で, 大小不同のある大型細胞で, 核
Publikováno v:
The Journal of Physical Chemistry A. 106:3403-3412
The imidazole ring of histidine exists in two tautomeric forms in neutral-to-basic aqueous solution, and the tautomerism of the histidine residue sometimes plays a key role in catalytic reactions of enzymes. We have investigated the molecular vibrati
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 6:85-89
The most essential information necessary for the treatment of bladder cancer is to know its exact staging. We have developed a percutaneous whole layer core biopsy (PC-WLCB) of the bladder tumor and applied it successfully since April 1985 for the st
Autor:
Takashi Kobayashi, Senji Hoshi, Kunio Ono, Mituharu Sasaki, Kenichi Suzuki, Akinori Muto, Osamu Sugano, Shunichi Saso, Masaaki Tukigi
Publikováno v:
International Journal of Urology. 14:79-81
Carcinosarcoma of the bladder is an unusual malignancy characterized by an intimate admixture of malignant epithelial elements (carcinoma) and malignant soft tissue elements (sarcoma). To our knowledge, almost 80 cases have been reported, usually as
Autor:
Kunio Ono, Yoshinori Kamiyama, Tomonori Habuchi, Yukio Kageyama, Kenji Numahata, Vladimir Bilim, Iwao Fukui, Kiyotaka Kawashima, Senji Hoshi
Publikováno v:
Journal of Urology. 189
INTRODUCTION AND OBJECTIVES: Recent studies showed therapeutic benefit from lymphadenectomy in advanced stage urothelial carcinoma of the upper urinary tract (UCUUT). However, there is still a lack of prospective studies and standardization of the ex